Endometriosis (EMs) is a common gynecological disorder in women of reproductive age, often presenting with pelvic pain and infertility. Its progression is closely linked to estrogen levels. While hormonal therapies …
Relugolix is an oral, non-peptide gonadotropin-releasing hormone receptor antagonist administered as once-daily combination therapy (relugolix-CT; 40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate) to reduce endometriosis symptoms while …
Choosing Between Newer GnRH Antagonist Therapies for Endometriosis Patient Care Online
Choosing Between Newer GnRH Antagonist Therapies for Endometriosis Contemporary OB/GYN
Oral GnRH Antagonists Expand Choice, Not Cure streamlinefeed.co.ke
Comparing GnRH Agonists and Antagonists for Endometriosis Pain Patient Care Online
Comparing GnRH Agonists and Antagonists for Endometriosis Pain Contemporary OB/GYN
Endometriosis is frequently managed with hormonal suppression that can induce hypoestrogenism during a period when many patients are still accruing peak bone mass. This narrative review summarizes current clinical and …
In women with uterine adenomyosis, bleeding and pain can have a major impact on quality of life. There is clearly widespread demand for effective long-term medical therapies. The objective of …
Endometriosis is a chronic inflammatory and estrogen-dependent disease in which pain remains the leading cause of impaired quality of life. Hormonal therapies constitute the cornerstone of medical management and include …